USRE32393F1 - Composition for enhancing the administration of pharmacologically active agents - Google Patents

Composition for enhancing the administration of pharmacologically active agents Download PDF

Info

Publication number
USRE32393F1
USRE32393F1 US60576084A USRE32393F1 US RE32393 F1 USRE32393 F1 US RE32393F1 US 60576084 A US60576084 A US 60576084A US RE32393 F1 USRE32393 F1 US RE32393F1
Authority
US
United States
Prior art keywords
enhancing
administration
composition
active agents
pharmacologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Application granted granted Critical
Publication of USRE32393E publication Critical patent/USRE32393E/en
Publication of USRE32393F1 publication Critical patent/USRE32393F1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
US06605760 1967-09-01 1984-08-14 Composition for enhancing the administration of pharmacologically active agents Expired - Lifetime USRE32393F1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1215967 1967-09-01
SE12159/67 1967-09-01

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US05/666,264 Division US4073943A (en) 1974-09-11 1976-03-12 Method of enhancing the administration of pharmalogically active agents
US05/854,404 Reissue US4168308A (en) 1976-03-12 1977-11-23 Composition for enhancing the administration of pharmacologically active agents

Publications (2)

Publication Number Publication Date
USRE32393E USRE32393E (en) 1987-04-07
USRE32393F1 true USRE32393F1 (en) 1990-05-29

Family

ID=20295252

Family Applications (1)

Application Number Title Priority Date Filing Date
US06605760 Expired - Lifetime USRE32393F1 (en) 1967-09-01 1984-08-14 Composition for enhancing the administration of pharmacologically active agents

Country Status (6)

Country Link
US (1) USRE32393F1 (en)
DE (1) DE1792410B2 (en)
DK (1) DK129272B (en)
FR (2) FR1593013A (en)
GB (1) GB1229967A (en)
NL (1) NL6812429A (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874605A (en) 1987-11-27 1989-10-17 Hoechst-Roussel Pharmaceuticals Inc. Stabilized delayed release emulsion
US4889525A (en) 1982-08-17 1989-12-26 Adamantech, Inc. Sensitization of hypoxic tumor cells and control of growth thereof
US4973465A (en) * 1986-12-05 1990-11-27 Ire-Celltarg S.A. Microcrystals comprising an active substance having an affinity for phospholipids, and at least one phospholipid, process of preparation
WO1990014837A1 (en) * 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US5560931A (en) * 1995-02-14 1996-10-01 Nawosystems L.L.C. Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5714520A (en) * 1994-03-22 1998-02-03 Zeneca Limited Propofol compostion containing edetate
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US6017545A (en) 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US20020006442A1 (en) * 1998-08-19 2002-01-17 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
US20030134908A1 (en) * 1994-03-22 2003-07-17 Jones Christopher Buchan Pharmaceutical compositions
US20030180367A1 (en) * 1996-08-22 2003-09-25 Skyepharma Canada, Inc. Microparticles of water-insoluble substances
US20040022819A1 (en) * 1993-10-07 2004-02-05 Takeshi Ikemoto Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US20060067952A1 (en) * 2004-09-28 2006-03-30 Sd Pharmaceuticals, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20060189700A1 (en) * 1994-03-22 2006-08-24 Astrazeneca Uk Limited Pharmaceutical compositions
US20060210622A1 (en) * 1999-09-21 2006-09-21 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US20070207173A1 (en) * 2006-02-01 2007-09-06 Sd Pharmaceuticals, Inc. Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US7939105B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US8415329B1 (en) 1998-05-29 2013-04-09 Jagotec Ag Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004580L (en) * 1980-06-19 1981-12-20 Draco Ab PHARMACEUTICAL PREPARATION
JPS6013779A (en) * 1983-07-05 1985-01-24 Green Cross Corp:The Prostaglandin i2 derivative
DE3339236A1 (en) * 1983-10-28 1985-05-09 Bayer Ag PREPARATION OF MEDICINAL PRODUCTS
DE3515335C2 (en) * 1985-04-27 1995-01-26 Bayer Ag Pharmaceutical preparation containing dihydropyridines and process for their preparation
DK159807C (en) * 1989-02-27 1992-06-29 Gunnar Kjems APPLICATION OF CALCIUM-SUSTAINABLE EMULSIONS FOR THE PREPARATION OF ORAL AGENTS FOR PREVENTION OR TREATMENT OF CALCIUM LACK OF Cattle, especially by calving fever
DE4107152C2 (en) * 1991-03-06 1994-03-24 Gregor Cevc Preparations for non-invasive administration of antidiabetics
DE4107153A1 (en) * 1991-03-06 1992-09-10 Gregor Cevc Compsns. for application of active agents
US8389551B2 (en) 2006-05-23 2013-03-05 Fermenta Biotech (Uk) Limited Optical enantiomers of phenyramidol and process for chiral synthesis
WO2020101585A1 (en) * 2018-11-16 2020-05-22 Santa Farma İlaç Sanayi̇ A.Ş. Solid oral pharmaceutical compositions comprising phenyramidol or salts thereof

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA659453A (en) * 1963-03-12 D. Mullins John Aqueous solutions of fat soluble vitamins
CA696819A (en) * 1964-10-27 Kelco Company Edible compositions comprising oil-in-water emulsions
NL292949A (en) *
DE397396C (en) * 1922-05-09 1924-06-20 Chem Ind Basel Process for making long-lasting emulsions of oil-soluble drugs
US2055083A (en) * 1932-07-13 1936-09-22 Winthrop Chem Co Inc Pharmaceutical preparation
DE707580C (en) * 1932-07-14 1941-06-26 I G Farbenindustrie Akt Ges Process for the preparation of emulsions containing therapeutically active substances for injection purposes
DE675966C (en) * 1935-08-25 1939-05-23 I G Farbenindustrie Akt Ges Process for the production of clear aqueous solutions of ethereal oils, camphor, terpenes
DE711777C (en) * 1937-09-21 1941-10-06 I G Farbenindustrie Akt Ges Process for the production of aqueous solutions or emulsions of poorly soluble physiologically active substances in water
US2303236A (en) * 1941-06-10 1942-11-24 Wm S Merrell Co Emulsion
GB744376A (en) * 1952-03-08 1956-02-08 Merck & Co Inc Vitamin emulsions
GB828312A (en) * 1955-06-10 1960-02-17 Donald Berthold Zilversmit Fat composition
US2832721A (en) * 1956-07-23 1958-04-29 Merck & Co Inc Vitamin emulsions
US2988484A (en) * 1956-07-24 1961-06-13 Drew & Co Inc E F Alcohol soluble pharmaceutical compositions
US2853419A (en) * 1956-09-07 1958-09-23 Merck & Co Inc Aqueous fat emulsions and process for preparing the same
US2867565A (en) * 1957-08-12 1959-01-06 Feinstone Wolffe Harry Sulfonamide composition comprising a lipid-aqueous emulsion carrier
US2972565A (en) * 1958-04-04 1961-02-21 Univ Tennessee Res Corp Fat composition
US3085939A (en) * 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3044931A (en) * 1960-01-27 1962-07-17 Geigy Chem Corp Aryloxy acetic acid amides: process for parenteral application
US3096249A (en) * 1960-05-10 1963-07-02 Samuel J Prigal Emulsion composition
GB914894A (en) * 1960-08-12 1963-01-09 Beecham Res Lab Injectable pharmaceutical media
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
NL269002A (en) * 1960-09-06
US3089823A (en) * 1961-09-05 1963-05-14 Eastman Kodak Co Aqueous vitamin a oil emulsion
US3216897A (en) * 1961-11-02 1965-11-09 Air Reduction Injectable anesthetic
US3185625A (en) * 1961-11-08 1965-05-25 Brown Ethan Allan Injectionable substances
GB1044623A (en) * 1961-11-16 1966-10-05 Marfleet Refining Company Ltd Improvements in and relating to glyceride esters and/or ethyl fatty esters
GB962209A (en) * 1962-04-19 1964-07-01 Upjohn Co Multi-vitamin compositions containing fluorides
GB1015251A (en) * 1963-03-12 1965-12-31 Glaxo Lab Ltd Aqueous pharmaceutical compositions in capsule form
DE1229677B (en) * 1963-10-25 1966-12-01 Nat Res Dev Process for the preparation of injectable emulsions containing antigens
GB1080994A (en) * 1963-10-25 1967-08-31 Nat Res Dev Injectable emulsions containing antigens
CH437995A (en) * 1963-11-01 1967-06-15 Hoffmann La Roche Process for the production of preparations containing lipophilic substances
FR3707M (en) * 1963-11-05 1965-11-22 Belge Produits Chimiques Sa Association of carnitine with lipid emulsions.
US3318770A (en) * 1964-01-16 1967-05-09 Geigy Chem Corp Intravenously injectable anesthetic composition
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
GB1035701A (en) * 1964-03-03 1966-07-13 Merck & Co Inc Emulsions suitable for use as adjuvants for immunological agents
US3384545A (en) * 1965-03-09 1968-05-21 Hoffmann La Roche Injectable aqueous emulsions of fat soluble vitamins
US3356575A (en) * 1965-04-13 1967-12-05 Leo Ab Autosterile injectable iodinated oil X-ray contrast medium
GB1081796A (en) * 1965-08-13 1967-08-31 Wright Fleming Inst Of Microbi Improvements in or relating to oily adjuvants for water-in-oil emulsions of antigenic materials
US3995118A (en) * 1975-07-03 1976-11-30 Bell Telephone Laboratories, Incorporated Call processing restoration arrangement for a telephone switching system

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889525A (en) 1982-08-17 1989-12-26 Adamantech, Inc. Sensitization of hypoxic tumor cells and control of growth thereof
US4973465A (en) * 1986-12-05 1990-11-27 Ire-Celltarg S.A. Microcrystals comprising an active substance having an affinity for phospholipids, and at least one phospholipid, process of preparation
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
US4874605A (en) 1987-11-27 1989-10-17 Hoechst-Roussel Pharmaceuticals Inc. Stabilized delayed release emulsion
WO1990014837A1 (en) * 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
US20090191226A2 (en) * 1989-05-25 2009-07-30 Novartis Vaccines And Diagnostics, Inc. Adjuvant formulation comprising a submicron oil droplet emulsion
US20030147898A1 (en) * 1989-05-25 2003-08-07 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulson
US6299884B1 (en) 1989-05-25 2001-10-09 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US20040022819A1 (en) * 1993-10-07 2004-02-05 Takeshi Ikemoto Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant
US20090098172A1 (en) * 1993-10-07 2009-04-16 Kao Corporation Surfactant, and emulsion cosmetic and liposome each containing the same
US20070292462A1 (en) * 1993-10-07 2007-12-20 Kao Corporation Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant
US5714520A (en) * 1994-03-22 1998-02-03 Zeneca Limited Propofol compostion containing edetate
US5908869A (en) * 1994-03-22 1999-06-01 Zeneca Limited Propofol compositions containing edetate
US20060189700A1 (en) * 1994-03-22 2006-08-24 Astrazeneca Uk Limited Pharmaceutical compositions
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US7125909B2 (en) 1994-03-22 2006-10-24 Astrazeneca Uk Limited Sterile parenteral nutrition compositions
US20030134908A1 (en) * 1994-03-22 2003-07-17 Jones Christopher Buchan Pharmaceutical compositions
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US5985941A (en) * 1994-05-16 1999-11-16 University Of Michigan Method of making hepatocyte-selective oil-in-water emulsion
US6126946A (en) * 1994-05-16 2000-10-03 University Of Michigan, The Board Of Regents Hepatocyte-selective oil-in-water emulsion
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5677341A (en) * 1994-12-07 1997-10-14 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5560931A (en) * 1995-02-14 1996-10-01 Nawosystems L.L.C. Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US20030180367A1 (en) * 1996-08-22 2003-09-25 Skyepharma Canada, Inc. Microparticles of water-insoluble substances
US8206746B2 (en) 1996-08-22 2012-06-26 Jagotec Ag Microparticles of water-insoluble substances
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US6017545A (en) 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US8415329B1 (en) 1998-05-29 2013-04-09 Jagotec Ag Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations
US20020006442A1 (en) * 1998-08-19 2002-01-17 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
US7097849B2 (en) 1998-08-19 2006-08-29 Jagotec Ag Injectable aqueous dispersions of propofol
US7041705B2 (en) 1998-08-19 2006-05-09 Jagotec Ag Injectable aqueous dispersions of propofol
US7939105B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US7939106B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US20060210622A1 (en) * 1999-09-21 2006-09-21 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
US20060067952A1 (en) * 2004-09-28 2006-03-30 Sd Pharmaceuticals, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20070207173A1 (en) * 2006-02-01 2007-09-06 Sd Pharmaceuticals, Inc. Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US8470873B2 (en) 2006-02-01 2013-06-25 Mast Therapeutics, Inc. Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof

Also Published As

Publication number Publication date
GB1229967A (en) 1971-04-28
DE1792410B2 (en) 1980-03-13
FR8152M (en) 1970-08-17
DE1792410A1 (en) 1971-11-11
NL6812429A (en) 1969-03-04
FR1593013A (en) 1970-05-25
DK129272C (en) 1975-02-10
DK129272B (en) 1974-09-23
USRE32393E (en) 1987-04-07

Similar Documents

Publication Publication Date Title
USRE32393F1 (en) Composition for enhancing the administration of pharmacologically active agents
MY7400330A (en) Pharmaceutical composition
BR6913699D0 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS
FI50707C (en) Process for the preparation of new pharmacologically active hydroxycyclohexylamines.
IT1062053B (en) PHARMACEUTICALLY ACTIVE AMMINOGUANIDINE PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT COMMENGOMO
MY7300271A (en) Pharmaceutical compositions
CY658A (en) Pharmaceutical compositions
IL29248A (en) Pharmacologically active 3-hydrazino-pyridazine derivatives
ZA717096B (en) Pharmaceutically active compounds
IL33788A (en) Pharmaceutically active thiachromone derivatives
MY7400206A (en) Pharmaceutical compositions
CA937562A (en) Pharmacologically effective substance from hazunta graciliflora
FI48841C (en) Process for the preparation of pharmacologically active 5-nitro-2-furfurylideneaminooxazolidinones.
IE31952B1 (en) Pharmaceutical compositions
IE32912B1 (en) Pharmaceutical compositions
CA771635A (en) Pharmacologically active compound
IE32574B1 (en) Pharmaceutically active phenyl-heterocyclic-alkanol derivatives
FI51188C (en) Process for the preparation of pharmacologically active substituted 2-oxo-benzothiazoline and benzoimidazoline compounds.
AU1932267A (en) Therapeutic compositions
AU418386B2 (en) Pharmacologically active compounds
IE31206L (en) Pharmaceutical composition
IE32198L (en) Pharmaceutical composition
ZM15969A1 (en) Pharmaceutically active compounds
CA764479A (en) Therapeutic agents
IE30805L (en) Pharmaceutical compositions containing¹bisphenylalkenylamines